Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Full Text
See detailPitted keratolysis: new ultrastructural insight in keratohyalin granule and corneodesmosome alterations.
Hermanns-Le, Trinh ULg; Garcia, R.; Arrese Estrada, Jean-Marie ULg et al

in Exogenous Dermatology : Physical, Chemical, Biological (2004), 3

Background: Pitted keratolysis (PK) is a superficial cutaneous infection caused by different species of bacteria. It is characterized by discrete crateriform and malodorous pits and erosions coalescing to ... [more ▼]

Background: Pitted keratolysis (PK) is a superficial cutaneous infection caused by different species of bacteria. It is characterized by discrete crateriform and malodorous pits and erosions coalescing to form bizarre figures on the soles. Objective: To investigate the process of corneocyte shedding in PK. Method: Biopsies from typical lesions of three patients were investigated by transmission electron microscopy. Results: Microorganisms were found both inter- and intracellularly in corneocytes and keratinocytes of the upper layers of the stratum spinosum. Bacteria exhibited different morphologic aspects related to their localisation in the epidermis. Keratohyalin granules were strikingly abnormal, showing sharp segregation between rounded dense areas and more electron-translucent areas. Some keratohyalin granules exhibited only alveolar dense areas. These altered keratohyalin granules were still present inside corneocytes. The corneodesmosomes at the bottom of the pits were in part cleaved leading to partial corneocyte dissociation. Conclusion: It is suggested that proteases secreted by the bacteria alter the structure of both the corneodesmosomes and the keratohyalin granules. The latter appeared more resistant to the normal processing of profilaggrin inside the corneocytes. [less ▲]

Detailed reference viewed: 58 (1 ULg)
Full Text
Peer Reviewed
See detailPituicyte stellation is prevented by RhoA-or Cdc42-dependent actin polymerization.
Rosso, Lia; Pierson, Patricia M; Golfier, Claire et al

in Cellular & Molecular Neurobiology (2007), 27(6), 791-804

Our aim was to shed light on different steps leading from metabotropic receptor activation to changes in cell shape, such as those that characterize the morphological plasticity of neurohypophysial ... [more ▼]

Our aim was to shed light on different steps leading from metabotropic receptor activation to changes in cell shape, such as those that characterize the morphological plasticity of neurohypophysial astrocytes (pituicytes). Using explant cultures of adult rat pituicytes, we have previously established that adenosine A1 receptor activation induces stellation via inhibition of RhoA monomeric GTPase and subsequent disruption of actin stress fibers. Here, we rule out RhoA phosphorylation as a mechanism for that inhibition. Rather, our results are more consistent with involvement of a GTPase-activating protein (GAP). siRNA and pull-down experiments suggest that a step downstream of RhoA might involve Cdc42, another GTPase of the Rho family. However, RhoA activation, e.g., in the presence of serum, induces stress fibers, whereas direct Cdc42 activation appears to confine actin within a submembrane - i.e., cortical - network, which also prevents stellation. Therefore, we propose that RhoA may activate Cdc42 in parallel with an effector, such as p160Rho-kinase, that induces and maintains actin stress fibers in a dominant fashion. Rac1 is not involved in the stellation process per se but appears to induce a dendritogenic effect. Ultimately, it may be stated that pituicyte stellation is inducible upon mere actin depolymerization, and preventable upon actin organization, be it in the form of stress fibers or in a cortical configuration. [less ▲]

Detailed reference viewed: 23 (1 ULg)
Full Text
See detailPituitary Adenomas
Beckers, Albert ULg; Beckers, Albert ULg

Textual, factual or bibliographical database (2002)

Detailed reference viewed: 15 (2 ULg)
Full Text
See detailPituitary Adenomas
Beckers, Albert ULg; Beckers, Albert ULg

Textual, factual or bibliographical database (2007)

Detailed reference viewed: 10 (0 ULg)
Full Text
See detailPituitary Adenomas
Beckers, Albert ULg; Beckers, Albert ULg

Textual, factual or bibliographical database (2001)

Detailed reference viewed: 16 (0 ULg)
Full Text
See detailPituitary Adenomas
Beckers, Albert ULg; Beckers, Albert ULg

Textual, factual or bibliographical database (2003)

Detailed reference viewed: 9 (0 ULg)
See detailPituitary Adenomas : Preoperative treatment of acromegaly
Beckers, Albert ULg

Scientific conference (2000, November 11)

Detailed reference viewed: 4 (0 ULg)
See detailPituitary adenomas : The underestimated prevalence
Beckers, Albert ULg

Scientific conference (2007, October 27)

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailPituitary adenomas in young patients : when should we consider a genetic predisposition ?
Jaffrain-Rea, M. L.; Tichomirova, M.; Daly, A. F. et al

in Expert Review of Endocrinology & Metabolism (2009), 4(6), 529-531

Detailed reference viewed: 9 (3 ULg)
Full Text
Peer Reviewed
See detailPituitary disease in MEN type 1 (MEN1): Data from the France-Belgium MEN1 multicenter study
Vergès, B.; Boureille, F.; Goudet, P. et al

in Journal of Clinical Endocrinology and Metabolism (2002), 87(2), 457-465

To date, data on pituitary adenomas in MEN type 1 (MEN1) still have to be evaluated. We analyzed the data of a large series of 324 MEN1 patients from a French and Belgian multicenter study. Data on ... [more ▼]

To date, data on pituitary adenomas in MEN type 1 (MEN1) still have to be evaluated. We analyzed the data of a large series of 324 MEN1 patients from a French and Belgian multicenter study. Data on pituitary disease were compared with those from 110 non-MEN1 patients with pituitary adenomas, matched for age, year of diagnosis, and follow-up period. Genetic analysis of the MEN1 gene was performed in 197 of the MEN1 patients. In our MEN1 series, pituitary disease occurred in 136 of 324 (42%), less frequently than hyperparathyroidism (95%, P < 0.001) and endocrine enteropancreatic tumors (54%, P < 0.01). Mean age of onset of pituitary tumors was 38.0 +/- 15.3 yr (range, 12-83 yr). Pituitary disease was associated with hyperparathyroidism in 90%. of cases, with enteropancreatic tumors in 47%, with adrenal tumors in 16%, and with thoracic neuroendocrine tumors in 4%. Pituitary disease was the initial lesion of MEN1 in 17% of all MEN1 patients. MEN1 pituitary adenomas were significantly more frequent in women than in men (50% vs. 31%,P < 0.001). Among the 136 pituitary adenomas, there were 85 prolactinomas and 12 GH-secreting, 6 ACTH-secreting, 13 cosecreting, and 20 nonsecreting tumors. Eighty-five percent of MEN1-related pituitary lesions were macroadenomas (vs. 42% in non-MEN1 patients, P < 0.001), including 32% of invasive cases. Among secreting adenomas, hormonal hypersecretion was normalized, after treatment, in only 42% (vs. 90% in non-MEN1 patients, P < 0.001), with a median follow-up of 11.4 yr. No correlation was found between the type of MEN1 germ-line mutation and the presence or absence of pituitary adenoma. Our study, based on a large group of MEN1 patients, shows that pituitary adenomas occur in 42% of the cases and are characterized by a larger size and a more aggressive presentation than without MEN1. [less ▲]

Detailed reference viewed: 71 (4 ULg)
See detailPituitary Diseases in Daily Clinical Pratice : Prevalence and Relevance 2006
Jaffrain-Réa, M. L.; Valle, L.; Daly, Adrian ULg et al

in Congrès Italien d'Endocrinologie : Florence, 2006 (2006)

Detailed reference viewed: 4 (0 ULg)
Full Text
Peer Reviewed
See detailPituitary incidentaloma : An Endocrine Society Clinical Practice Guideline
Freda, Pamela; Beckers, Albert ULg; Katznelson, Laurence et al

in Journal of Clinical Endocrinology and Metabolism (2011)

Detailed reference viewed: 147 (7 ULg)
Full Text
See detailPituitary magnetic resonance imaging in gigantism : first result after analysis of 16 cases
BECK, Emmanuel ULg; KREUTZ, Julie ULg; TSHIBANDA, Luaba ULg et al

in 23rs meeting of the Belgian Endocrine Society - Abstract book (2013, October 19)

Detailed reference viewed: 17 (4 ULg)
Full Text
Peer Reviewed
See detailPituitary microadenomas: diagnosis with two-and three-dimensional MR imaging at 1.5 T before and after injection of gadolinium.
Stadnik, T.; Stevenaert, Achille ULg; Beckers, Albert ULg et al

in Radiology (1990), 176(2), 419-428

The usefulness of different magnetic resonance (MR) imaging sequences (coronal and sagittal spin-echo [SE] and three-dimensional fast low-angle shot [3D FLASH]) in the detection of pituitary microadenomas ... [more ▼]

The usefulness of different magnetic resonance (MR) imaging sequences (coronal and sagittal spin-echo [SE] and three-dimensional fast low-angle shot [3D FLASH]) in the detection of pituitary microadenomas before and after gadolinium injection was prospectively evaluated in 28 patients with surgical confirmation. When evaluated separately, the most useful sequences in the detection of these microadenomas were coronal pregadolinium T1-weighted SE, coronal pregadolinium 3D FLASH, coronal postgadolinium T1-weighted SE, and coronal postgadolinium 3D FLASH. The combination of pre- and postgadolinium T1-weighted sequences with pre-and postgadolinium 3D FLASH sequences produced the highest number of true-positive findings (90%) and the lowest number of false-positive findings (5%). When a 1.5-T imaging unit with a high signal-to-noise ratio allowing useful three-dimensional acquisition is used, the authors advocate a coronal T1-weighted SE sequence, followed (if necessary) by a coronal 3D FLASH sequence, both without injection of gadolinium, in the diagnosis of pituitary microadenomas. When no confident diagnosis is reached, the same sequences should be performed after the injection of gadolinium. The sagittal pre- and postgadolinium T1-weighted SE and long-TR SE sequences are useful only in specific cases. [less ▲]

Detailed reference viewed: 32 (1 ULg)
Full Text
Peer Reviewed
See detailPITUITARY-HORMONES DEPENDENT EXPRESSION OF INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II IN THE IMMATURE HYPOPHYSECTOMIZED RAT TESTIS
Closset, Jean ULg; Gothot, André ULg; SENTE, Béatrice et al

in Molecular Endocrinology (1989), 3(7), 1125-1131

Detailed reference viewed: 26 (6 ULg)
Peer Reviewed
See detailPituitary-specific factor binding to the human prolactin, growth hormone, and placental lactogen genes
Lemaigre, F. P.; Peers, Bernard ULg; Lafontaine, D. A. et al

in DNA (1989), 8(3), 149-59

The human genes coding for growth hormone (GH), chorionic somatomammotropin (placental lactogen, CS), and prolactin (Prl) are related evolutionarily but are expressed in phenotypically distinct cell types ... [more ▼]

The human genes coding for growth hormone (GH), chorionic somatomammotropin (placental lactogen, CS), and prolactin (Prl) are related evolutionarily but are expressed in phenotypically distinct cell types despite their nucleotide sequence homology. We show here that the promoters of the human Prl and CS genes contain cis-acting sequences that confer pituitary-specific expression in a cell-free transcription assay. Similar data are obtained with the human GH gene, consistent with earlier work by others. Footprinting analysis shows that neighboring sequences in each of these three promoters are protected from deoxyribonuclease I digestion by rat pituitary cell extracts. Footprinting competition experiments and gel retardation assays with synthetic oligonucleotides suggest that a single factor is responsible for the pituitary-specific footprints seen on the human Prl, CS, and GH genes. They also suggest that this factor is identical or closely related to the trans-acting factor GHF-1/Pit-1. Similarities with and differences from the rat GH and Prl genes are discussed. [less ▲]

Detailed reference viewed: 16 (0 ULg)
Full Text
Peer Reviewed
See detailPitx factors are involved in basal and hormone-regulated activity of the human prolactin promoter
Quentien, M. H.; Manfroid, Isabelle ULg; Moncet, D. et al

in Journal of Biological Chemistry (2002), 277(46), 44408-44416

The pituitary-specific POU homeodomain factor Pit-1 likely interacts with other factors for cell-specific expression of prolactin. Here we identify the paired-like homeobox transcription factors Pitx1 and ... [more ▼]

The pituitary-specific POU homeodomain factor Pit-1 likely interacts with other factors for cell-specific expression of prolactin. Here we identify the paired-like homeobox transcription factors Pitx1 and Pitx2 as factors functionally activating the proximal human prolactin promoter (hPRL-164luc). Using in vitro binding assays and a series of site-specific mutations of the proximal hPRL promoter, we mapped the 131 and B2 bicoid sites involved in Pitx-mediated transactivation of the hPRL-164luc construct. In somatolactotroph GH4C1 cells, basal proximal hPRL promoter activity was inhibited by a Pitx2 dominant-negative form in a dose-dependent manner, whereas binding disruptive mutations in the Pitx sites significantly reduced basal activity of the promoter. We also show that synergistic activation of hPRL-164luc by Pitx2 and Pit-1 requires the integrity of the B2 Pitx binding site, and at least one of the P1 and P2 Pit-1 response elements. In addition, mutation in the B2 Pitx site results in attenuation of the promoter's responsiveness to forskolin, thyrotropin-releasing hormone, and epidermal growth factor. Conversely, Pitx1 or Pitx2 overexpression in GH4C1 cells leads to an enhancement of the drugs stimulatory effects. Altogether, these results suggest that full responsiveness to several signaling pathways regulating the hPRL promoter requires the B2 Pitx binding site and that Pitx factors may be part of the proteic complex involved in these regulations. Finally, in situ hybridization analysis showing coexpression of the PRL and Pitx2 genes in rat and human lactotroph cells corroborates the physiological relevance of these results. [less ▲]

Detailed reference viewed: 10 (1 ULg)
Full Text
See detailPityriasis versicolor anhidrotique.
Uhoda, Emmanuelle ULg; Franchimont, Claudine ULg; Pierard, Gérald ULg

in Dermatologie Actualité (2005), 89

Detailed reference viewed: 15 (0 ULg)